Ranbaxy to discontinue Gladerma products marketing
Pharmaceutical major Ranbaxy Laboratories is set to discontinue marketing a range of dermatological products of French company, Gladerma. The move is a direct consequence of Galderma's plans to set up its own operations in the country.

KSEB not to provide escrow cover to NTPC power plan
The Kerala State Electricity Board (KSEB) will not provide escrow cover to the National Thermal Power Corporation's (NTPC) Kayamkulam Thermal Power Plant. NTPC is set to commission the first stage of its Phase I, 350mw naphtha-fired combined cycle plant on November 1, Kerala Day.

Dr Reddy's Labs buys out 5 Dolphin Labs brands
The Hyderabad-based pharma major Dr Reddy's Laboratories Ltd on Wednesday announced the outright acquisition of five brands and the manufacturing and marketing rights for another from Dolphin Laboratories Ltd.

  Grichard Wagoner to head new GM unit, takes lead for CEO job
  Advanced Micro reports surprise profit
  Guangdong failure sparks alarm in China
  Loewen warns investors about earnings again, shakes up board
  World Briefing
  Sony India unpacks new ware; chalks out plan to expand product range
  Ministry cautious on ONGC stake in Bina project
  Firms do not see economic turnaround before Feb'99
  Airbus Industrie to stretch domestic product portfolio
  L&T set to partner Madras Refineries' for 400mw Manali power venture
  Alcatel set to walk out of Koshika Telecom lock, debt and equity
  India Foils plans to increase share capital to Rs 130 crore
  Baroda Rayon Corp sells off prime Mumbai property to IL&FS
  BPL Mobile unveils `intelligent' network
  Zuari Industries may cease production at Goa facility
  M&M to earmark Rs 800 cr for Project Scorpio
  Corporate Briefing
  Daewoo flags off Matiz output, still uptight on price
  IDBI ropes in Arthur Andersen to help narrow asset-liability mismatch
  Reliance H1 net seen rising 11 per cent